©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jan 28, 2005; 11(4): 482-487
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.482
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.482
Table 4 Impact of ANA detection on sustained biochemical response of the patients.
| Biochemical response at the end of follow up [n (%)] | ||||
| n | Yes | No | P | |
| ANA entry | ||||
| Pos | 31 | 13 (41.9) | 18 (58.1) | 0.017 |
| Neg | 26 | 20 (76.9) | 6 (23.1) | |
| ANA end of follow up | ||||
| Pos | 41 | 20 (48.8) | 21 (51.2) | 0.037 |
| Neg | 16 | 13 (81.3) | 3 (18.7) | |
- Citation: Gatselis NK, Georgiadou SP, Tassopoulos N, Zachou K, Liaskos C, Hatzakis A, Dalekos GN. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study. World J Gastroenterol 2005; 11(4): 482-487
- URL: https://www.wjgnet.com/1007-9327/full/v11/i4/482.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i4.482